GH Research PLC’s September 2026 foreign private issuer report was signed on September 11, 2026, by Company Secretary Magnus Halle. For investors, the document confirms the reporting period and identifies the authorized company officer who signed it on behalf of the Nasdaq-listed company.
Key Highlights
- The document carries the U.S. Securities and Exchange Commission heading for Washington, D.C. 20,549.
- Magnus Halle signed the report as GH Research PLC’s Company Secretary.
- In September 2026, GH Research PLC presented a report under the Securities Exchange Act of 1934 as a foreign private issuer.
September 2026 Reporting Period
Investors can identify both the reporting period and the date attached to the communication. The report is presented under the Securities Exchange Act of 1934. Its heading identifies the U.S. Securities and Exchange Commission and Washington, D.C. 20,549. The document is designated for the month of September 2026.
Company Secretary Signs Report
Magnus Halle signed the document for GH Research PLC (NASDAQ: GHRS) on September 11, 2026. The signature identifies Halle as Company Secretary. The report states that it was signed on the company’s behalf by a duly authorized person.
FAQs
Q: What did GH Research PLC report in September 2026?
A: In September 2026, GH Research PLC presented a report under the Securities Exchange Act of 1934 as a foreign private issuer. The reported material contains no operating, financial, or transaction information.
Q: Who signed the GH Research PLC report?
A: Company Secretary Magnus Halle signed the GH Research PLC report on September 11, 2026. The document states that he signed on behalf of the company as a duly authorized person.
Q: What does the GHRS report identify for investors?
A: The GHRS report identifies September 2026 as its reporting month and records the September 11, 2026 signature date. It also names Magnus Halle as Company Secretary.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.